Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021
暂无分享,去创建一个
A. Copas | C. Fuller | M. Shrotri | L. Shallcross | T. Palmer | P. Moss | M. Krutikov | B. Azmi | G. Tut | R. Giddings | A. Irwin-Singer
[1] A. Copas,et al. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study , 2021, The Lancet Infectious Diseases.
[2] S. Schrag,et al. Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021 , 2021, MMWR. Morbidity and mortality weekly report.
[3] J. Farrar,et al. Study Protocol: Understanding SARS-Cov-2 infection, immunity and its duration in care home residents and staff in England (VIVALDI) , 2021, Wellcome open research.
[4] J. Farrar,et al. Study Protocol: Understanding SARS-Cov-2 infection, immunity and its duration in care home residents and staff in England (VIVALDI). , 2020, Wellcome open research.
[5] T. Rea,et al. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington , 2020, The New England journal of medicine.